Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | IONS |
---|---|---|
09:32 ET | 1070 | 47.5 |
09:34 ET | 200 | 47.39 |
09:36 ET | 2685 | 47.6 |
09:38 ET | 500 | 47.595 |
09:39 ET | 4333 | 47.65 |
09:41 ET | 157 | 47.595 |
09:43 ET | 1778 | 47.77 |
09:45 ET | 1278 | 47.725 |
09:48 ET | 300 | 47.78 |
09:50 ET | 3383 | 47.79 |
09:52 ET | 2169 | 47.74 |
09:54 ET | 23927 | 47.76 |
09:56 ET | 2335 | 47.57 |
09:57 ET | 25210 | 47.73 |
09:59 ET | 3600 | 47.59 |
10:01 ET | 20203 | 47.7 |
10:03 ET | 3951 | 47.47 |
10:06 ET | 17342 | 47.415 |
10:08 ET | 5087 | 47.17 |
10:10 ET | 3525 | 47.2 |
10:12 ET | 1752 | 47.205 |
10:14 ET | 959 | 47.165 |
10:15 ET | 3920 | 47.3098 |
10:17 ET | 2465 | 47.245 |
10:19 ET | 42378 | 47.22 |
10:21 ET | 2839 | 47.15 |
10:24 ET | 3568 | 47.065 |
10:26 ET | 1731 | 47.02 |
10:28 ET | 2250 | 47.24 |
10:30 ET | 3337 | 47.3 |
10:32 ET | 3111 | 47.3 |
10:33 ET | 2508 | 47.458 |
10:35 ET | 200 | 47.42 |
10:37 ET | 2640 | 47.46 |
10:39 ET | 829 | 47.455 |
10:42 ET | 3359 | 47.52 |
10:44 ET | 36833 | 47.535 |
10:46 ET | 805 | 47.55 |
10:48 ET | 400 | 47.56 |
10:50 ET | 710 | 47.515 |
10:51 ET | 100 | 47.52 |
10:53 ET | 1614 | 47.51 |
10:55 ET | 32997 | 47.5 |
10:57 ET | 2654 | 47.37 |
11:00 ET | 2100 | 47.5 |
11:02 ET | 1729 | 47.475 |
11:04 ET | 2200 | 47.49 |
11:06 ET | 1000 | 47.51 |
11:08 ET | 871 | 47.47 |
11:09 ET | 9239 | 47.4801 |
11:11 ET | 1000 | 47.51 |
11:13 ET | 18805 | 47.56 |
11:15 ET | 643 | 47.54 |
11:18 ET | 7113 | 47.54 |
11:20 ET | 2078 | 47.521 |
11:22 ET | 500 | 47.52 |
11:24 ET | 4070 | 47.41 |
11:26 ET | 2059 | 47.42 |
11:27 ET | 5049 | 47.44 |
11:29 ET | 11126 | 47.5 |
11:31 ET | 2315 | 47.48 |
11:33 ET | 11941 | 47.5 |
11:36 ET | 5774 | 47.47 |
11:38 ET | 1300 | 47.465 |
11:40 ET | 2641 | 47.5 |
11:42 ET | 1100 | 47.56 |
11:44 ET | 2147 | 47.5 |
11:45 ET | 5343 | 47.5 |
11:47 ET | 3737 | 47.55 |
11:49 ET | 2627 | 47.57 |
11:51 ET | 721 | 47.555 |
11:54 ET | 3135 | 47.49 |
11:56 ET | 1011 | 47.49 |
11:58 ET | 2207 | 47.38 |
12:00 ET | 1388 | 47.43 |
12:02 ET | 2419 | 47.43 |
12:03 ET | 500 | 47.34 |
12:05 ET | 702 | 47.26 |
12:07 ET | 3865 | 47.3 |
12:09 ET | 61536 | 47.415 |
12:12 ET | 2538 | 47.54 |
12:14 ET | 4807 | 47.47 |
12:16 ET | 1100 | 47.52 |
12:18 ET | 67178 | 47.51 |
12:20 ET | 2117 | 47.475 |
12:21 ET | 1350 | 47.54 |
12:23 ET | 561 | 47.49 |
12:25 ET | 1219 | 47.45 |
12:27 ET | 6073 | 47.38 |
12:30 ET | 1175 | 47.305 |
12:32 ET | 3952 | 47.375 |
12:34 ET | 750 | 47.34 |
12:36 ET | 5969 | 47.35 |
12:38 ET | 400 | 47.36 |
12:39 ET | 791 | 47.345 |
12:41 ET | 5107 | 47.33 |
12:43 ET | 1680 | 47.3139 |
12:45 ET | 662 | 47.34 |
12:48 ET | 790 | 47.33 |
12:50 ET | 661 | 47.33 |
12:52 ET | 4959 | 47.38 |
12:54 ET | 1507 | 47.41 |
12:56 ET | 36884 | 47.48 |
12:57 ET | 7000 | 47.59 |
12:59 ET | 655 | 47.57 |
01:01 ET | 8786 | 47.53 |
01:03 ET | 873 | 47.57 |
01:06 ET | 24013 | 47.565 |
01:08 ET | 3117 | 47.515 |
01:10 ET | 2100 | 47.43 |
01:12 ET | 98024 | 47.55 |
01:14 ET | 440 | 47.53 |
01:15 ET | 4900 | 47.535 |
01:17 ET | 918 | 47.53 |
01:19 ET | 2950 | 47.51 |
01:21 ET | 2300 | 47.515 |
01:24 ET | 300 | 47.495 |
01:26 ET | 3641 | 47.4896 |
01:28 ET | 410 | 47.47 |
01:30 ET | 2397 | 47.505 |
01:32 ET | 1296 | 47.49 |
01:33 ET | 1194 | 47.49 |
01:35 ET | 4464 | 47.43 |
01:37 ET | 4622 | 47.485 |
01:39 ET | 1900 | 47.49 |
01:42 ET | 3091 | 47.44 |
01:44 ET | 1200 | 47.35 |
01:46 ET | 1420 | 47.42 |
01:48 ET | 2800 | 47.395 |
01:50 ET | 400 | 47.44 |
01:51 ET | 600 | 47.44 |
01:53 ET | 208 | 47.44 |
01:55 ET | 1555 | 47.44 |
01:57 ET | 3495 | 47.515 |
02:00 ET | 2221 | 47.46 |
02:02 ET | 523 | 47.455 |
02:04 ET | 823 | 47.4 |
02:06 ET | 3351 | 47.4 |
02:08 ET | 15073 | 47.525 |
02:09 ET | 1700 | 47.555 |
02:11 ET | 1127 | 47.56 |
02:13 ET | 6739 | 47.53 |
02:15 ET | 2407 | 47.57 |
02:18 ET | 12479 | 47.6 |
02:20 ET | 3118 | 47.51 |
02:22 ET | 2401 | 47.54 |
02:24 ET | 700 | 47.5 |
02:26 ET | 4562 | 47.44 |
02:27 ET | 20224 | 47.33 |
02:29 ET | 2876 | 47.295 |
02:31 ET | 5052 | 47.3 |
02:33 ET | 2368 | 47.375 |
02:36 ET | 6195 | 47.36 |
02:38 ET | 1520 | 47.38 |
02:40 ET | 2744 | 47.45 |
02:42 ET | 3400 | 47.45 |
02:44 ET | 3905 | 47.44 |
02:45 ET | 4549 | 47.47 |
02:47 ET | 1227 | 47.465 |
02:49 ET | 1777 | 47.48 |
02:51 ET | 3360 | 47.43 |
02:54 ET | 6184 | 47.37 |
02:56 ET | 42927 | 47.39 |
02:58 ET | 6100 | 47.45 |
03:00 ET | 1010 | 47.42 |
03:02 ET | 1827 | 47.425 |
03:03 ET | 7702 | 47.43 |
03:05 ET | 200 | 47.33 |
03:07 ET | 2025 | 47.36 |
03:09 ET | 2744 | 47.265 |
03:12 ET | 3557 | 47.19 |
03:14 ET | 2400 | 47.19 |
03:16 ET | 4773 | 47.2 |
03:18 ET | 3100 | 47.25 |
03:20 ET | 700 | 47.2 |
03:21 ET | 627 | 47.22 |
03:23 ET | 5282 | 47.22 |
03:25 ET | 22130 | 47.335 |
03:27 ET | 3914 | 47.27 |
03:30 ET | 2761 | 47.29 |
03:32 ET | 2003 | 47.29 |
03:34 ET | 4049 | 47.25 |
03:36 ET | 4157 | 47.23 |
03:38 ET | 2156 | 47.24 |
03:39 ET | 4095 | 47.19 |
03:41 ET | 5173 | 47.12 |
03:43 ET | 7793 | 47.2 |
03:45 ET | 6838 | 47.29 |
03:48 ET | 9961 | 47.37 |
03:50 ET | 7139 | 47.305 |
03:52 ET | 11364 | 47.28 |
03:54 ET | 14289 | 47.12 |
03:56 ET | 21201 | 47.17 |
03:57 ET | 36416 | 47.27 |
03:59 ET | 50120 | 47.23 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Ionis Pharmaceuticals Inc | 6.9B | -17.7x | --- |
Halozyme Therapeutics Inc | 6.7B | 21.5x | --- |
Intra-Cellular Therapies Inc | 7.6B | -61.7x | --- |
Blueprint Medicines Corp | 6.7B | -22.5x | --- |
Legend Biotech Corp | 7.9B | -17.2x | --- |
Tempus AI Inc | 4.1B | -17.3x | --- |
Ionis Pharmaceuticals, Inc. is engaged in ribonucleic acid (RNA)-targeted therapeutics. The Company has five marketed medicines and a pipeline in neurology, cardiology, and other areas of high patient need. It has nine medicines in Phase III development and multiple additional medicines in early and mid-stage development. The Company’s products include SPINRAZA, QALSODY, WAINUA, TEGSEDI and WAYLIVRA. SPINRAZA is used for the treatment of patients with spinal muscular atrophy (SMA), a progressive, debilitating and often fatal genetic disease. QALSODY is an antisense medicine that is used for the treatment of adult patients with superoxide dismutase 1 amyotrophic lateral sclerosis (SOD1-ALS), a rare, neurodegenerative disorder that causes progressive loss of motor neurons leading to death. WAINUA is a self-administered subcutaneous LIgand-Conjugated Antisense (LICA) medicine used for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated amyloidosis (ATTRv-PN).
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $6.9B |
---|---|
Revenue (TTM) | $776.6M |
Shares Outstanding | 146.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.40 |
EPS | $-2.67 |
Book Value | $2.68 |
P/E Ratio | -17.7x |
Price/Sales (TTM) | 8.8 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -48.38% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.